Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Anticoagulation in obese patients: challenges and strategies

Alice Lipari, Esmeralda Capristo, Antonietta Ferretti, Erica De Candia

18-09-2025

https://doi.org/10.4081/btvb.2025.174

172

PDF: 32

HTML: 22
Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

24-03-2025

https://doi.org/10.4081/btvb.2025.155

286

PDF: 88
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

16-05-2024

https://doi.org/10.4081/btvb.2024.115

833

PDF: 338
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1176

PDF: 380

APPENDIX: 77
The key to fibrinolysis and thrombolysis

Roger Lijnen, Désiré Collen

09-09-2025

https://doi.org/10.4081/btvb.2025.368

222

PDF: 52

HTML: 34
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4754

PDF: 411

Supplementary Files: 132
Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

Marco Marietta, Giancarlo Castaman

01-07-2025

https://doi.org/10.4081/btvb.2025.180

1251

PDF: 405
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

15-04-2022

https://doi.org/10.4081/btvb.2022.9

739

PDF: 235

Supplementary Files: 84
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

27-06-2023

https://doi.org/10.4081/btvb.2023.84

1368

PDF: 314

Supplementary File: 168
The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

https://doi.org/10.4081/btvb.2023.76

2321

PDF: 901
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

https://doi.org/10.4081/btvb.2024.137

1164

PDF: 300
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

https://doi.org/10.4081/btvb.2023.92

858

PDF: 256
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

23-05-2022

https://doi.org/10.4081/btvb.2022.28

5279

PDF: 479

APPENDIX: 0
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

21-03-2023

https://doi.org/10.4081/btvb.2023.59

634

PDF: 244
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

2122

PDF: 249
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

919

PDF: 283
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

Gary E. Raskob

16-05-2024

https://doi.org/10.4081/btvb.2024.124

672

PDF: 353
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

03-11-2022

https://doi.org/10.4081/btvb.2022.42

964

PDF: 309
The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

Armando Tripodi

23-01-2025

https://doi.org/10.4081/btvb.2025.169

751

PDF: 242
Management of atrial fibrillation: a practical and useful synopsis of last guidelines

Gualtiero Palareti

24-02-2025

https://doi.org/10.4081/btvb.2025.168

801

PDF: 18
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.113

632

PDF: 362
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

27-01-2023

https://doi.org/10.4081/btvb.2023.60

769

PDF: 330
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

https://doi.org/10.4081/btvb.2024.108

920

PDF: 446
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2080

PDF: 560
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

https://doi.org/10.4081/btvb.2024.131

1452

PDF: 249
Polycythemia vera and management of the thrombotic risk: an update

Massimo Franchini

20-12-2023

https://doi.org/10.4081/btvb.2023.102

1995

PDF: 310
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

22-03-2022

https://doi.org/10.4081/btvb.2022.20

1553

PDF: 478
Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

Paolo Prandoni

11-10-2023

https://doi.org/10.4081/btvb.2023.97

1574

PDF: 255
A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

Sergio Coccheri

24-10-2022

https://doi.org/10.4081/btvb.2022.48

1734

PDF: 291

1 - 29 of 29 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy